Literature DB >> 9098991

Urinary excretion of deprenyl metabolites.

J Lengyel1, K Magyar, I Hollósi, T Bartók, M Báthori, H Kalász, S Fürst.   

Abstract

(+)-Deprenyl metabolites in rat's urine, such as nordeprenyl. methamphetamine amphetamine and p-hydroxy. methamphetamine were identified by HPLC-MS. After oral administration of 10 mg of pure (-)- and (+)-deprenyl to human volunteers, their urine was analyzed by gas chromatography. The concentration of methamphetamine was found to be overwhelming in the case of the (-)-isomer, while amphetamine and methamphetamine were excreted in equal amounts when (+)-deprenyl was administered. The metabolic processes of deprenyl resulted in metabolites possessing different lipophilicity, as it has been shown by planar displacement chromatography.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098991     DOI: 10.1016/s0021-9673(97)00009-5

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  5 in total

1.  R-deprenyl: pharmacological spectrum of its activity.

Authors:  K Magyar; B Szende; V Jenei; T Tábi; M Pálfi; E Szöko
Journal:  Neurochem Res       Date:  2010-08-20       Impact factor: 3.996

2.  Structural elucidation by electrospray mass spectrometry: an approach to the in vitro metabolism of the macrolide immunosuppressant SDZ RAD.

Authors:  C Vidal; G I Kirchner; K F Sewing
Journal:  J Am Soc Mass Spectrom       Date:  1998-12       Impact factor: 3.109

3.  Chromatographic investigation and computer simulation of L-deprenyl metabolism.

Authors:  Z S Tarjányi; H Kalász; I Hollósi; M Báthori; T Bartók; J Lengyel; K Maguar; S Fürst
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

4.  Biotransformation of deprenyl enantiomers.

Authors:  E Szökö; H Kalász; K Magyar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Oct-Dec       Impact factor: 2.441

Review 5.  Metabolism of monoamine oxidase inhibitors.

Authors:  G B Baker; L J Urichuk; K F McKenna; S H Kennedy
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.